Lv1
52 积分 2023-05-17 加入
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
18小时前
已完结
The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors
7天前
已完结
Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response
7天前
已完结
Dysplastic epithelial repair promotes the tissue residence of lymphocytes to inhibit alveolar regeneration post viral infection
1个月前
已完结
Dysplastic epithelial repair promotes the tissue residence of lymphocytes to inhibit alveolar regeneration post viral infection
1个月前
已完结
Interception of Regulatory RNAs on TGF-β Signaling in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Systematic Review
2个月前
已完结
Nerandomilast in patients with progressive pulmonary fibrosis
2个月前
已完结
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
2个月前
已完结
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
2个月前
已完结
Tracing the origins of lung fibrosis
2个月前
已完结
皖公网安备34019202002308
